✦ LIBER ✦

Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma

✍ Scribed by Ann Y. Minn; Elyn Riedel; Jerry Halpern; Laura J. Johnston; Sandra J. Horning; Richard T. Hoppe; Karyn A. Goodman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes for patients who fail high dose

✍ Alison J. Moskowitz; Miguel-Angel Perales; Tarun Kewalramani; Joachim Yahalom; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Effect of rituximab on the long-term out

✍ Georg Hess; Thomas Flohr; Karin Kolbe; Sarah Bonn; Martin Schuler; Hans Günter D 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 359 KB

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Long-term survival and late relapse in 2

✍ Navneet S. Majhail; Ruta Bajorunaite; Hillard M. Lazarus; Zhiwei Wang; John P. K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Reduced-intensity conditioning for allog

✍ Karl S. Peggs; Anna Sureda; Wendi Qian; Dolores Caballero; Ann Hunter; Alvaro Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

High-dose therapy with peripheral blood

✍ K. Neben; S. Hohaus; H. Goldschmidt; G. Egerer; M. T. Voso; A. D. Ho; R. Haas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB